🇺🇸 FDA

Intelligence Platform

Patents

Browse 62 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9688748

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and m

CytomX Therapeutics, Inc. · Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9644016

Soluble notch receptor proproteins and methods of use thereof

CytomX Therapeutics, Inc. · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9562073

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods

CytomX Therapeutics, Inc. · Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9545442

Activatable antibodies that bind epidermal growth factor receptor and methods of use there

CytomX Therapeutics, Inc. · Granted Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9540440

Activatable antibodies that bind epidermal growth factor receptor and methods of use there

CytomX Therapeutics, Inc. · Granted Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9517276

Compositions and methods for conjugating activatable antibodies

CytomX Therapeutics, Inc. · Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9487590

Activatable antibodies that bind interleukin-6 receptor and methods of use thereof

CytomX Therapeutics, Inc. · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9453078

Modified antibody compositions, methods of making and using thereof

CytomX Therapeutics, Inc. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9127053

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and m

CytomX Therapeutics, Inc. · Granted Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9120853

Activatable antibodies that bind epidermal growth factor receptor and methods of use there

CytomX Therapeutics, Inc. · Granted Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993266

Proproteins activatable interferon alpha

CytomX Therapeutics, Inc. · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563269

Modified antibody compositions, methods of making and using thereof

CytomX Therapeutics, Inc. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8513390

Modified antibody compositions, methods of making and using thereof

CytomX Therapeutics, Inc. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8399219

Protease activatable interferon alpha proprotein

CytomX Therapeutics, Inc. · Granted Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted